Insight Lifetech Co., Ltd. (SHA:688712)
China · Delayed Price · Currency is CNY 29.26
-0.38 (-1.28%)
Sep 14, 2026, 10:05 AM CST
Insight Lifetech Revenue
Insight Lifetech had revenue of 201.27M CNY in the quarter ending June 30, 2026, with 53.23% growth. This brings the company's revenue in the last twelve months to 669.84M, up 55.69% year-over-year. In the year 2025, Insight Lifetech had annual revenue of 542.09M with 71.22% growth.
Revenue (ttm)
669.84M
Revenue Growth
+55.69%
P/S Ratio
18.45
Revenue / Employee
866.55K
Employees
673
Market Cap
12.36B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 542.09M | 225.48M | 71.22% |
| Dec 31, 2024 | 316.60M | 132.63M | 72.09% |
| Dec 31, 2023 | 183.98M | 91.53M | 99.00% |
| Dec 31, 2022 | 92.45M | 40.69M | 78.61% |
| Dec 31, 2021 | 51.76M | 50.09M | 2,991.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Autobio Diagnostics | 4.22B |
| Cofoe Medical Technology | 3.96B |
| Shandong Weigao Blood Purification Products | 3.76B |
| Double Medical Technology | 2.73B |
| Qingdao Haier Biomedical Co.,Ltd | 2.43B |
| Jafron Biomedical | 1.91B |
| MeHow Innovative | 1.71B |
| Shandong Weigao Orthopaedic Device | 1.49B |